Lymphoma Clinical Trials in Baltimore

Showing 741-742 of 742 trials

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

NCT00333008

The purpose of this study is to evaluate the feasibility and tolerability of delivering a full dose, on time schedule of dose-dense CDOP-R (cyclophosphamide, doxil, vincristine, prednisone, and rituximab) in NHL.

Diffuse Large B Cell LymphomaLymphoma, Non-Hodgkin

The Alvin and Lois Lapidus Cancer Institute27 participantsStarted May 2006

Baltimore, Maryland, United States • Randallstown, Maryland, United States

COMPLETEDPhase 236 miles

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

NCT00045864

The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with intermediate-and high- grade Non-Hodgkin's lymphoma.

Lymphoma, Non-Hodgkin

Chiron Corporation

Tucson, Arizona, United States • Newport Beach, California, United States • Sacramento, California, United States +30 more locations

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Lymphoma Trials in Other Cities

Other Conditions in Baltimore